TBX1 Is Responsible for Cardiovascular Defects in Velo-Cardio-Facial/DiGeorge Syndrome
Sandra Merscher,Birgit Funke,Jonathan A. Epstein,Joerg Heyer,Anne Puech,Min Min Lu,Ramnik J. Xavier,Marie B. Demay,Robert G. Russell,Stephen Factor,Kazuhito Tokooya,Bruno St. Jore,Melissa Lopez,Raj K. Pandita,Marie Lia,Danaise Carrion,Hui Xu,Hubert Schorle,James B. Kobler,Peter Scambler,Anthony Wynshaw-Boris,Arthur I. Skoultchi,Bernice E. Morrow,Raju Kucherlapati
DOI: https://doi.org/10.1016/s0092-8674(01)00247-1
IF: 64.5
2001-02-01
Cell
Abstract:Velo-cardio-facial syndrome (VCFS)/DiGeorge syndrome (DGS) is a human disorder characterized by a number of phenotypic features including cardiovascular defects. Most VCFS/DGS patients are hemizygous for a 1.5-3.0 Mb region of 22q11. To investigate the etiology of this disorder, we used a cre-loxP strategy to generate mice that are hemizygous for a 1.5 Mb deletion corresponding to that on 22q11. These mice exhibit significant perinatal lethality and have conotruncal and parathyroid defects. The conotruncal defects can be partially rescued by a human BAC containing the TBX1 gene. Mice heterozygous for a null mutation in Tbx1 develop conotruncal defects. These results together with the expression patterns of Tbx1 suggest a major role for this gene in the molecular etiology of VCFS/DGS.
cell biology,biochemistry & molecular biology